1-2 of 2
Srikanth Muralikrishnan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of Venetoclax and Azacytidine As First-Line Induction Therapy for Acute Myeloid Leukemia in Patients Younger Than 60 Years: A Tertiary Care Center Experience from Our Low Middle Income Country

Aditya Sanjeevi, Logesh Durairaj, Uddiptya Goswami, Deepak George, Jeyasankar Subramanian, Jose M Easow, Srikanth Muralikrishnan, Nirusha Muralitharan, Cecili Stanislasus
Journal: Blood
Blood (2023) 142 (Supplement 1): 5865.
https://doi.org/10.1182/blood-2023-185738
Published: 2023
Journal Articles

Aminopeptidase Inhibition as a Targeted Treatment Strategy in Myeloma.

Faith E. Davies, MD, Hannah E. Moore, Emma L. Davenport, PhD, Alan S. Dunlop, Srikanth Muralikrishnan, David Krige, PhD, Leon Hooftman, MD, Gareth Morgan, PhD
Journal: Blood
Blood (2007) 110 (11): 2505.
https://doi.org/10.1182/blood.V110.11.2505.2505
Published: 2007